Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBDC

Apotheca Biosciences (CBDC) Stock Price, News & Analysis

Apotheca Biosciences logo

About Apotheca Biosciences Stock (NASDAQ:CBDC)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$0.0002
$0.0002
50-Day Range
$0.00
$0.08
52-Week Range
$0.00
$0.31
Volume
N/A
Average Volume
21,204 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Apotheca Biosciences, Inc. develops cutting-edge medical products, nutraceuticals, formulations, and delivery technologies for the healthcare and consumer care industry in the United States. The company's products include transdermal, sublingual, and nasal delivery devices for dosing of cannabinoids. It also provides CBD pain cream, gel capsules, patches, and sleep tablets; and Promed, anti-aging and cosmetic products. The company was incorporated in 2014 and is based in Saint Petersburg, Florida.

Remove Ads
Receive CBDC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apotheca Biosciences and its competitors with MarketBeat's FREE daily newsletter.

CBDC Stock News Headlines

Apotheca Biosciences Inc
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

CBDC Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Apotheca Biosciences investors own include SoFi Technologies (SOFI), Andersons (ANDE), British American Tobacco (BTI), Copa (CPA), Cronos Group (CRON), FREYR Battery (FREY) and Kraft Heinz (KHC).

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:CBDC
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:CBDC) was last updated on 4/4/2025 by MarketBeat.com Staff
From Our Partners